Edition:
United States

Origo Acquisition Corp (OACQ.OQ)

OACQ.OQ on NASDAQ Stock Exchange Capital Market

10.65USD
8 Dec 2017
Change (% chg)

$-0.05 (-0.47%)
Prev Close
$10.70
Open
$10.70
Day's High
$10.70
Day's Low
$10.65
Volume
3,469
Avg. Vol
1,168
52-wk High
$11.50
52-wk Low
$10.10

Latest Key Developments (Source: Significant Developments)

Origo says co, units executed 1st amendment to merger agreement to amend & restate certain terms and provision
Tuesday, 3 Oct 2017 05:44pm EDT 

Oct 3 (Reuters) - Origo Acquisition Corp :Origo - ‍on Sept 27, co, units executed first amendment to merger agreement to amend and restate certain terms and provision of merger agreement​.Origo - ‍amendment provides HTH shall be permitted to increase amount of HTH's existing secured loan from exworks capital fund ito upto $11.5 million.Origo says amendment provides if merger is not terminated, hth permitted to enter into private placement financings for not less than $135 million - SEC Filing.  Full Article

Hightimes seeks public listing through business combination with Origo
Thursday, 27 Jul 2017 08:50am EDT 

July 27 (Reuters) - Origo Acquisition Corp :Hightimes holding corp. Seeks public listing through business combination with origo acquisition corporation.Origo acquisition corp - high times existing equity valued at approximately $250 million in the merger.Origo acquisition corp - high times’ management team, led by adam levin, will continue to run the combined company post-transaction.Origo acquisition corp - origo will acquire 100% of the equity of high times in exchange for 23.5 million newly-issued shares of origo.Origo acquisition-at closing, current shareholders of high times, co to hold about 83% and 17%, respectively, of shares of publicly traded co’s stock.Origo acquisition corp - two current members of the origo board, or their designees, will join high times as independent directors.Origo acquisition corp - the boards of directors of both high times and origo have unanimously approved the proposed transaction.  Full Article

Aina Le'a Inc- no termination fees regarding termination of merger agreement with Origo Acquisition Corporation
Friday, 23 Dec 2016 04:44pm EST 

Aina Le'a Inc :Aina Le'a Inc- there are no termination fees in connection with termination of merger agreement with Origo Acquisition Corporation.  Full Article

CB Pharma Acquisition gets extension to complete initial business combination
Friday, 10 Jun 2016 01:55pm EDT 

CB Pharma Acquisition Corp: CB Pharma Acquisition Corp. announces approval of proposals to extend time to complete initial business combination . Company now has until December 12, 2016 to complete initial business combination . Edward J. Fred appointed as Chief Executive Officer; Jose M. Aldeanueva appointed Chief Financial Officer .Lindsay Rosenwald, Michael Weiss, George Avgerinos, Adam Chill, Arthur Kornbluth, Neil Herskowitz resigned as an officer and/or director.  Full Article

BRIEF-Origo says co, units executed 1st amendment to merger agreement to amend & restate certain terms and provision

* Origo - ‍on Sept 27, co, units executed first amendment to merger agreement to amend and restate certain terms and provision of merger agreement​

No consensus analysis data available.